LifeSign Status COVID-19/Flu A&B Test Kit

A simple and efficient rapid lateral flow immunoassay test used by healthcare professionals for the detection and differentiation of Coronavirus (Sars-CoV-2) antigen, Influenza A and/or Influenza B on symptomatic patients. Approved for point-of-care testing, CLIA-waived, and has FDA Emergency Use Authorization (EUA), the specimen is collected directly through anterior nasal or nasopharyngeal swabbing, within the first five (5) days of symptoms onset on individuals who are suspected of respiratory viral infection consistent with COVID-19. Accurate and fast results will be shown on the test device in as fast as 15 minutes.